☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
alteogen
Alteogen and Daiichi Sankyo Partner to Develop and Commercialize SC Formulation of Enhertu
November 11, 2024
Alteogen Signed an Exclusive License Agreement with Sandoz to Develop and Commercialize Biosimilar Products
January 3, 2023
Insights+ Key Biosimilars Events of March 2021
April 1, 2021
PharmaShots Weekly Snapshots (Mar 08 - 12, 2021)
March 12, 2021
Top 20 Life Sciences Deals of 2020 by Total Deal Value
January 22, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
